| Revenue growth | +54.87% YoY to ₹171.22 cr consolidated |
|---|---|
| Margins | EBITDA margin ~6.6% vs ~7.2% prior year; contracted |
| Demand visibility | Peroxide, salicylate, acrylic demand cited; no quantified visibility |
| Management confidence | Upbeat MD tone; no numeric forward guidance |
Growth
Revenue +54.87%, EBITDA +43.00%, PAT +1,709% off a ₹0.19 cr base. EBITDA margin fell to ~6.6% from ~7.2%.
Outlook
No quantified growth guidance. Acrylics capacity ~2,000 to ~4,500 T/month; salicylic acid ~50 to ~200 T/month; Dahej and Tarapur expansions.
Risks
EBITDA margin compression. Working capital efficiency is a stated priority. Limited global availability of certain peroxide raw materials.
Investor Presentation filed with NSE, NSE: AMBANIORGO. Summary written with AI assistance from the document.
Ambani Orgochem Ltd: key numbers
- Share price
- ₹155.05
- Market cap
- ₹116.9 Cr
- Revenue (annual)
- ₹240.7 Cr
- Net profit (annual)
- ₹1.33 Cr
- P/E (TTM)
- 87.6×Sector 34.5×
- Promoter holding
- 52.59%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Ambani Orgochem Ltd
All →Ambani Orgochem Convertible Warrants
Ambani Orgochem members approved a Rs 43.93 Crore preferential warrant issue and capital changes. Promoters receive 30.1 lakh of the 43.93 lakh warrants.
- Value
- ₹43.93 Cr
Ambani Orgochem Annual General Meeting
Ambani Orgochem's 1st EGM on 26 October 2026 took up four special resolutions. Items cover authorised capital, the capital clause, and preferential warrants.
Ambani Orgochem Convertible Warrants
Ambani Orgochem issued a corrigendum to its EGM notice, reducing the proposed preferential issue size of convertible warrants to Rs. 43.925 Crore following allotment revisions.
- Value
- ₹43.92 Cr
Ambani Orgochem Convertible Warrants
Ambani Orgochem reduced its proposed preferential issue of convertible warrants by Rs. 0.25 Crore, following the removal of one allottee. The revised issue size is Rs. 43.925 Crore.
- Value
- ₹43.92 Cr
Ambani Orgochem Other Announcement
The company submitted its Reconciliation of Share Capital Audit Report for the quarter ended September 30, 2026, in compliance with SEBI Regulation 76.
Ambani Orgochem Annual General Meeting
Ambani Orgochem Limited seeks shareholder approval at an EGM to issue 43.95 lakh convertible warrants at Rs. 100 each, raising Rs. 43.95 Crore.
- Value
- ₹43.95 Cr